MedTrace Logo

Tryptase and Coronary Heart Disease

NCT01618279 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2022-01-25

No results posted yet for this study

Summary

The main aim of this study will evaluate differences in serum levels of tryptase in study population. Will be selected a number of 350 patients hospitalized for coronary heart disease.

Conditions

  • Acute Coronary Syndrome With ST Elevation on Electrocardiogram
  • Acute Coronary Syndrome Without ST Elevation on Electrocardiogram
  • Noncritical Coronary Artery Disease Coronary Stenosis Less Than 50 Per Cent
  • Aortic Aneurysms

Sponsors & Collaborators

  • Niguarda Hospital

    lead OTHER

Principal Investigators

  • Elide Anna Pastorello, MD, Professor · Azienda Ospedaliera Ospedale Niguarda Ca' Granda

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2021-12-31
Completion
2022-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01618279 on ClinicalTrials.gov